Golden
Medison Ventures

Medison Ventures

Medison Ventures is the venture capital arm of Medison Pharma, based in Israel.

Medison Ventures is a venture capital and private equity firm investing in pharmaceutical, biotechnology, and digital healthcare companies that is headquartered in Tikva, Israel and was founded in 2016 by Meir Jakobsohn. Medison Ventures in the corporate venture capital arm of Medison, a commercial partner for global pharma companies in Israel, Canada, and CEE markets. All companies receiving investment from Medison Ventures gain access to the scientific, commercial, regulatory, and clinical knowledge of Medison. These companies also gain access to the global pharma partners of Medison such as Biogen, Vertex, Shire, Biomarin, IPSEN, Servier, PTC Therapeutics, and Daiichi-Sankyo.



Investments

Notable investments made by Medison Ventures include: Keros Therapeutics, Eloxx Pharmaceuticals, AlphaTAU, Apeiron Biologics, Allogene Therapeutics, Orchard Therapeutics, and ArQule. 



Investment funds

Venture debt fund

In 2019 Medison Ventures and Pontifax launched a venture debt fund with $150 million in funding to provide clinical-stage life science companies with non-dilutive funding. 



Timeline

Funded Companies

1 Result
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

Alpha Tau Medical provides highly potent and conformal Alpha Radiotherapy (Alpha DaRT) for solid cancer tumors.

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References